https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

The call for FORTALECE and Platforms of the Instituto de Salud Carlos III is open until September 12

1 de August de 2023

Each call has a budget of 30 million euros to finance health research and innovation projects

 

On July 27th, the ISCIII opened the FORTALECE call for Health Research Institutes and the ISCIII Platforms call for support for R&D&I in Biomedicine and Health Sciences. Each call has a funding of 30 million €.

 

FORTALECE Call for Health Research Institutes accredited by the ISCIII

The FORTALECE call addressed to Health Research Institutes (IIS) of the Instituto de Salud Carlos III (ISCIII) is the first representation of FORTALECE, a new global program of science funding, more flexible and less bureaucratic, which seeks to consolidate and promote research groups in Spain and which will be developed over the next decade.

FORTALECE is intended to finance projects developed in Health Research Institutes (IIS) accredited by the ISCIII. It will have 30 million to finance during this year a forecast of 72 research groups from different IIS, so that each selected group will receive an average of 100,000 euros per year on the first day of the year, a stable funding for four years to develop their main lines of work.

To apply for grants, ISCIII-accredited IIS research groups must explain what their proposal consists of, explain its development, define the scientific strategy of the project and specify how the funds received will be used. The form should include, in general terms, a brief narrative description of the proposal and the expected incentive effect on the lines of research, the definition of the chosen groups, the specific clinical-health care issues to be solved, and the development of the frontier science expected to be obtained.

Call for applications (link)

More information (link)

The deadline for applications begins on July 27 and ends on September 12.

 

Call for ISCIII Platforms to support R&D&I in Biomedicine and Health Sciences

This 2023 call for R&D&I support platforms in Biomedicine and Health Sciences will consolidate the activity of the ISCIII Platform for Clinical Research Support (SCREN), the ISCIII Platform for Biomodels and Biobanks (PNBB) and the ISCIII Platform for Dynamization and Innovation of the industrial capacities of the NHS and their effective transfer to the productive sector (ITEMAS). It will have 30 million for the next three years (2023-2025), with annual grants of 10 million.

Call for proposals (link)

More information (link)

The deadline for applications begins on July 27 and ends on September 12.